SOTERA HEALTH COMPANY Derivative Asset, Fair Value, Gross Asset
SOTERA HEALTH COMPANY (SHC) had Derivative Asset, Fair Value, Gross Asset of $3.98 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Offsetting
us-gaap:DerivativeFairValueOfDerivativeAsset · last filed 2026-08-06
- 2026-06-30: Derivative Asset, Fair Value, Gross Asset $3.98M.
- 2026-03-31: Derivative Asset, Fair Value, Gross Asset $2.04M.
- 2025-12-31: Derivative Asset, Fair Value, Gross Asset $1.16M.
- 2025-06-30: Derivative Asset, Fair Value, Gross Asset $2.13M.
| Period end | Derivative Asset, Fair Value, Gross Asset |
|---|---|
| 2026-06-30 | $3.98M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $2.04M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.16M 10-Q · filed 2026-08-06 |
| 2025-06-30 | $2.13M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $3.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $3.24M 10-K · filed 2026-02-24 |
| 2024-06-30 | $7.00M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $12.15M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $11.62M 10-K · filed 2025-02-27 |
| 2023-06-30 | $27.29M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $26.67M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $37.48M 10-K · filed 2024-02-27 |
| 2022-03-31 | $20.45M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $4.47M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |